PS
CRL icon

Principal Securities’s Charles River Laboratories CRL Stock Holding History

Principal Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
6,753
+253
+4% +$45.1K 0.02% 643
2026
Q1 		$1.12M Buy
6,500
+427
+7% +$79.2K 0.02% 694
2025
Q4 		$1.21M Buy
6,073
+1,810
+42% +$328K 0.02% 640
2025
Q3 		$667K Buy
4,263
+209
+5% +$33.2K 0.01% 801
2025
Q2 		$615K Sell
4,054
-162
-4% -$21.6K 0.01% 774
2025
Q1 		$778K Hold
4,216
– – 0.02% 631
2024
Q4 		$778K Sell
4,216
-144
-3% -$27.7K 0.02% 626
2024
Q3 		$859K Buy
4,360
+15
+0.3% +$3.12K 0.02% 579
2024
Q2 		$898K Buy
4,345
+33
+0.8% +$7.48K 0.02% 503
2024
Q1 		$1.17M Buy
4,312
+1,091
+34% +$261K 0.04% 417
2023
Q4 		$761K Buy
+3,221
New +$633K 0.03% 483

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Principal Securities's CRL Position: Q2 2026 in Review

Principal Securities increased its Charles River Laboratories (CRL) stake by 3.9% in Q2 2026, buying an estimated $45.1K and bringing the position to 6,753 shares worth $1.53M. The position accounts for 0.02% of the portfolio, ranked #643.

Principal Securities first reported a position in CRL in Q4 2023 and has held it in 11 quarters since. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Principal Securities held 6,753 shares of Charles River Laboratories worth $1.53M as of Q2 2026.
  • Principal Securities bought 253 Charles River Laboratories shares in Q2 2026, an estimated $45.1K.
  • Charles River Laboratories made up 0.02% of Principal Securities's portfolio in Q2 2026, its #643 holding.
  • Principal Securities first reported a position in Charles River Laboratories in Q4 2023 and has held it in 11 quarters since.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.